Shirley, Matt
Article History
First Online: 8 September 2020
Change Date: 22 October 2020
Change Type: Correction
Change Details: The article Triheptanoin: First Approval, written by Matt Shirley, was originally published electronically in SpringerLink on 8 September 2020 without open access. After publication in volume 80, issue 15, pages 1595���1600 Ultragenyx Pharmaceutical Inc., requested that the article be Open Choice to make the article an open access publication.
Declarations
:
: The preparation of this review was not supported by any external funding.
: During the peer review process the manufacturer of the agent under review was offered an opportunity to comment on the article. Changes resulting from comments received were made by the author on the basis of scientific completeness and accuracy. Matt Shirley is a salaried employee of Adis International Ltd/Springer Nature, is responsible for the article content and declares no relevant conflicts of interest.
: Not applicable.